ABEONA THERAPEUTICS INC. Lessee, Operating Lease, Liability, to be Paid, Year One
ABEONA THERAPEUTICS INC. (ABEO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.29 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.29M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.29M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $864.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $419.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $1.29M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $864.00K 10-K · filed 2026-03-17 |
| 2025-09-30 | $419.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.10M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.04M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $853.00K 10-K · filed 2025-03-20 |
| 2024-09-30 | $853.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $853.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.55M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $998.00K 10-K · filed 2024-03-18 |
| 2023-09-30 | $993.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $993.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.81M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.77M 10-K · filed 2023-03-29 |
| 2022-09-30 | $1.83M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.83M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.83M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.82M 10-K · filed 2022-03-31 |
| 2021-09-30 | $1.73M 10-Q · filed 2021-11-15 |
| 2020-12-31 | $1.71M 10-K · filed 2021-03-24 |
| 2020-09-30 | $1.71M 10-Q · filed 2020-11-09 |
| 2019-12-31 | $1.70M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |